NEOPLASMS BY HISTOLOGIC TYPE
Clinical trials for NEOPLASMS BY HISTOLOGIC TYPE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS BY HISTOLOGIC TYPE trials appear
Sign up with your email to follow new studies for NEOPLASMS BY HISTOLOGIC TYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged immune cells aim to stop lymphoma comeback
Disease control OngoingThis early-phase trial tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma who have had a stem cell transplant. The treatment uses the patient's own T cells, which are modified in a lab to recognize and attack cancer cells that carry a protein called CD30. The m…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 23, 2026 18:08 UTC
-
Could a cancer drug cut surgeries for rare throat growths?
Disease control OngoingThis study tests whether bevacizumab, a drug that blocks blood vessel growth, can reduce how often people with recurrent respiratory papillomatosis (RRP) need surgery to clear wart-like growths from their airways. About 21 adults who need at least two surgeries per year will rece…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Engineered immune cells take aim at Hard-to-Treat lymphoma
Disease control OngoingThis study tests a new treatment for people with CD30-positive Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard therapies. The treatment involves taking a patient's own T cells, adding a gene that helps them recognize and attack CD30 on cancer cells,…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
Robotic surgery or radiation? new study compares which is better for throat cancer patients' quality of life
Symptom relief OngoingThis study compares two treatments for early-stage throat cancer: robotic surgery (TORS) or radiation therapy (IMRT). It looks at which one leads to better swallowing function and overall quality of life. About 138 adults with HPV-related throat cancer are taking part. The goal i…
Matched conditions: NEOPLASMS BY HISTOLOGIC TYPE
Phase: NA • Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated May 27, 2026 23:06 UTC